The Effect of Various Substances on the Suppression of the Bitterness of Quinine-Human Gustatory Sensation, Binding, and Taste Sensor Studies
スポンサーリンク
概要
- 論文の詳細を見る
The purpose of this study was to quantify the degree of suppression of the perceived bitterness of quinine by various substances and to examine the mechanism of bitterness suppression. The following compounds were tested for their ability to suppress bitterness: sucrose, a natural sweetener; aspartame, a noncaloric sweetener; sodium chloride (NaCl) as the electrolyte; phosphatidic acid, a commercial bitterness suppression agent; and tannic acid, a component of green tea. These substances were examined in a gustatory sensation test in human volunteers, a binding study, and using an artificial taste sensor. Sucrose, aspartame, and NaCl were effective in suppressing bitterness, although at comparatively high concentrations. An almost 80% inhibition of bitterness (calculated as concentration %) of a 0.1 mM quinine hydrochloride solution required 800 mM of sucrose, 8 mM of aspartame, and 300 mM NaCl. Similar levels of bitterness inhibition by phosphatidic acid and tannic acid (81.7, 61.0%, respectively) were obtained at much lower concentrations (1.0 (w/v)% for phosphatidic acid and 0.05 (w/v)% for tannic acid). The mechanism of the bitterness-depressing effect of phosphatidic acid and tannic acid was investigated in terms of adsorption and masking at the receptor site. With phosphatidic acid, 36.1% of the bitterness-depressing effect was found to be due to adsorption, while 45.6% was due to suppression at the receptor site. In the case of 0.05 (w/v)% tannic acid, the total bitterness-masking effect was 61.0%. The contribution of the adsorption effect was about 27.5% while the residual masking effect at the receptor site was almost 33%. Further addition of tannic acid (0.15 (w/v)%), however, increased the bitterness score of quinine, which probably represents an effect of the astringency of tannic acid itself. Finally, an artificial taste sensor was used to evaluate or predict the bitterness-depressing effect. The sensor output profile was shown to reflect the depressant effect at the receptor site rather well. Therefore, the taste sensor is potentially useful for predicting the effectiveness of bitterness-depressant substances.
- 公益社団法人日本薬学会の論文
- 2002-12-01
著者
-
TANIGAKE Atsu
School of Pharmaceutical Sciences, Mukogawa Women's University
-
MIYANAGA Yohko
School of Pharmaceutical Sciences, Mukogawa Women's University
-
NAKAMURA Tomoko
School of Pharmaceutical Sciences, Mukogawa Women's University
-
MATSUYAMA Kenji
School of Pharmaceutical Sciences, Mukogawa Women's University
-
UCHIDA Takahiro
School of Pharmaceutical Sciences, Mukogawa Women's University
-
Miyanaga Y
School Of Pharmaceutical Sciences Mukogawa Women's University
-
Miyanaga Yohko
School Of Pharmaceutical Sciences Mukogawa Women's University
-
Tanigake Atsu
School Of Pharmaceutical Sciences Mukogawa Women's University
-
AKIYOSHI Takeshi
School of Pharmaceutical Sciences, Mukogawa Women s University
-
Nakamura Tomoko
School Of Pharmaceutical Sciences Mukogawa Women S University
-
Matsuyama Kenji
School Of Pharmaceutical Sciences Mukogawa Women's University
-
Matsuyama Kenji
Department Of Hospital Pharmacy Nagasaki University Hospital:faculty Of Pharmaceutical Sciences Kyus
-
Matsuyama Kenji
Department Of Clinical Pharmacy Faculty Of Pharmaceutical Sciences Mukogawa Women's University
-
Uchida Takahiro
School Of Pharmaceutical Sci. Mukogawa Women's Univ.
-
OGAWA Tazuko
School of Pharmaceutical Sciences, Mukogawa Women's University
-
Matsuyama K
Department Of Clinical Pharmacy Kyoritsu University Of Pharmacy
-
Ogawa T
R & D Division Daiichi Sankyo Co. Ltd.
-
Nakamura T
School Of Pharmaceutical Sciences Mukogawa Women's University
-
Akiyoshi Takeshi
School Of Pharmacy And Pharmaceutical Sciences Mukogawa Women's University
-
Nakabayashi T
School Of Pharmacy And Pharmaceutical Sciences Mukogawa Women's University
関連論文
- O13-013 クラリスロマイシンDSの粒度別評価(一般演題 口頭発表,調剤・処方鑑査・リスクマネジメント/医薬品情報・データベース/有害事象・副作用,医療薬学の創る未来 科学と臨床の融合)
- O13-014 アンブロキソール錠10製剤の苦味評価 : 温度の影響(一般演題 口頭発表,調剤・処方鑑査・リスクマネジメント/医薬品情報・データベース/有害事象・副作用,医療薬学の創る未来 科学と臨床の融合)
- クラリスロマイシンドライシロップの先発品および後発品の品質評価
- 先発品と後発品の味の比較 : ユークリッド距離を用いた評価
- 30-P2-88 肝不全栄養剤に及ぼすフレーバーの添加効果の解析 : プロビット法による苦味閾値の測定(調剤,社会の期待に応える医療薬学を)
- 20-P3-489 急性中毒における薬剤師の役割 : 不良ボンベ缶からの曝露による臭化メチル中毒の1症例(薬物動態(臨床),来るべき時代への道を拓く)
- P2-305 高カロリー輸液投与時の脂肪乳剤併用による肝障害抑制効果の検討(一般演題 ポスター発表,薬物療法(栄養管理、NST),医療薬学の創る未来 科学と臨床の融合)
- 21-P3-517 セーフティーキャップ普及に向けての提言 : 薬剤師の立場から(使用状況調査・意識調査,来るべき時代への道を拓く)
- O13-012 クレメジン^[○!R]細粒の吸着性と服用性におよぼす市販嚥下補助ゼリーの影響(一般演題 口頭発表,調剤・処方鑑査・リスクマネジメント/医薬品情報・データベース/有害事象・副作用,医療薬学の創る未来 科学と臨床の融合)
- 21D-04 漢方薬服用ゼリーによる服用性の改善効果(調剤・処方鑑査(内用薬),来るべき時代への道を拓く)
- 21D-03 クラリスロマイシンドライシロップ12製剤の品質評価 : 含量均一性と服用性の評価(調剤・処方鑑査(内用薬),来るべき時代への道を拓く)
- 21D-02 味覚センサを用いた後発品・先発品の服用性評価(調剤・処方鑑査(内用薬),来るべき時代への道を拓く)
- 21C-16 抗生剤の調製方法の違いによる医療経済的考察(後発医薬品・医療経済等,来るべき時代への道を拓く)
- 味センサを用いた苦味評価系の構築と製剤設計への応用
- SD法による小児用抗菌薬の服用性評価
- 小児用抗菌薬の服用性に関する研究 : 懸濁・分散性および苦味強度の評価を中心として
- 30-P2-89 Prednisolone散内服時の最適苦味抑制法について(調剤,社会の期待に応える医療薬学を)
- 29-A3-14-1 クラリスロマイシンドライシロップの先発・後発品の品質比較:服用性のスコア化(調剤・服薬指導・薬剤管理指導,社会の期待に応える医療薬学を)
- 29-A3-13-5 クラリスロマイシンドライシロップの先発・後発品の品質比較:製剤均一性試験(調剤・服薬指導,社会の期待に応える医療薬学を)
- 抗菌剤の内服コンプライアンス向上を目指して : 味覚センサによる苦味予測とその活用
- 経腸栄養剤の味評価 : 医薬品の服用感に関する研究 第23報
- P-675 生薬の味評価および品質管理への味覚センサの応用(12.調剤・処方管理、オーダリング(注射剤含む)3,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)
- P-674 SD法による半消化態経腸栄養剤の服用感の評価(12.調剤・処方管理、オーダリング(注射剤含む)3,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)
- P-673 服薬補助ゼリーの苦味抑制効果(12.調剤・処方管理、オーダリング(注射剤含む)3,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)
- P-672 クラリスロマイシンDSの味に及ぼす併用散剤の影響(12.調剤・処方管理、オーダリング(注射剤含む)3,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)
- 味覚センサを用いたマクロライド系ドライシロップの苦味評価 : 苦味マスキングに関する報告第22報
- オルニチンのBCAA類に対する苦味抑制効果
- 薬学教育6年制の早期体験学習に関する学生へのアンケート調査とその解析
- 薬学教育6年制の早期体験学習の受け入れ施設へのアンケート調査とその解析
- 30-P3-38 重症心身障害児/者施設における早期体験学習とその評価(薬学教育,社会の期待に応える医療薬学を)
- 29-P3-48 病院、薬局における早期体験学習の成果について : 学生へのアンケート調査から(薬学教育,社会の期待に応える医療薬学を)
- 29-P1-149 維持透析下で塩酸アムルビシンを投与し薬物体内動態を検討した小細胞肺癌の1例(TDM/薬物動態,社会の期待に応える医療薬学を)
- P-53 5-FU持続注入における携帯型持続注入ポンプの流量特性 : 薬液粘度・温度の影響(2.癌薬物療法(外来化学療法、緩和ケア等)3,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)
- SD法を用いた小児用ドライシロップ・細粒の服用性の評価
- The Bitterness Intensity of Clarithromycin Evaluated by a Taste Sensor
- 最近の技術 疲労回復を促進する苦味を抑えたアミノ酸食品の開発
- 経口苦味マスキング製剤の品質評価 (特集 製剤の工夫で患者ベネフィットを上げる)
- 29-P1-23 光遮へい型微粒子測定装置を用いた注射剤配合変化の評価(NST,社会の期待に応える医療薬学を)
- 29-A3-14-2 味覚センサによるテオフィリンドライシロップの先発・後発品の味評価(調剤・服薬指導・薬剤管理指導,社会の期待に応える医療薬学を)
- ユークリッド距離を利用した生薬・漢方製剤の味評価
- 苦味を抑制するアミノ酸の発見!
- BIO R&D オルニチンの苦味マスキング効果
- P-258 保険調剤薬局における時間外問合わせの実態調査とその解析(17.在宅医療・医薬分業,"薬剤師がつくる薬物治療"-薬・薬・学の連携-)
- ジェネリック医薬品の潮流 (ジェネリック医薬品を考える)
- O11-09 クラリスロマイシン製剤の苦味に及ぼすカルボシステイン製剤またはアンブロキソール製剤のpHの影響(一般演題 口頭発表,調剤・処方鑑査・オーダリングシステム,臨床から学び臨床へと還元する医療薬学)
- O11-10 アンブロキソール錠10製剤の苦味強度に及ぼす温度の影響 : 溶出量と苦味閾値の関与について(一般演題 口頭発表,調剤・処方鑑査・オーダリングシステム,臨床から学び臨床へと還元する医療薬学)
- P-577 ゼリーによる苦味抑制効果の定量化 : 薬物溶解度の影響(14.調剤・処方管理・オーダリング(注射剤含む),"薬剤師がつくる薬物治療"-薬・薬・学の連携-)
- Integrins α2β1, α5β1 and αvβ5 Are Related to Tumor Growth and Metastasis of Non-small Cell Lung Cancer
- Effect of Quinine Solutions on Intracellular Ca^Levels in Neuro-2a Cells : Conventional Physiological Method for the Evaluation of Bitterness(Miscellaneous)
- Clinical Efficacy of Shitei-decoction for Hiccups
- Consideration on Prevention of Phlebitis and Venous Pain from Intravenous Prostaglandin E_1 Administration by Adjusting Solution pH : In Vitro Manipulations Affecting pH
- Suppression of the Bitterness of Enteral Nutrients Using Increased Particle Sizes of Branched-Chain Amino Acids (BCAAs) and Various Flavours : a Taste Sensor Study
- Evaluation of Bitterness Suppression of Macrolide Dry Syrups by Jellies
- ENHANCED HEPATITIS OF ISONIAZID INDUCED BY RIFAMPICIN COADMINISTRATION. ROLE OF THE ISONIAZID METABOLITE, HYDRAZINE
- FURTHER INVESTIGATIONS ON BRAIN DISTRIBUTION OF HYDRA ZINE AND ITS γ-AMINOBUTYRIC ACID ELEVATING EFFECT IN RATS
- BRAIN DISTRIBUTION OF HYDRAZINE AND ITS GABA ELEVATING EFFECT IN RATS
- Growth Inhibition, Morphological Change, and Ectoenzyme Release of LLC-PK1 Cells by Phosphatidylinositol-specific Phospholipase C of Bacillus thuringiensis
- Release of Ectoenzymes from Small Intestine Brush Border Membranes of Mice by Phospholipases
- THE STABILIZING ACTION OF HYDROXYPYRUVALDEHYDE PHENYLOSAZONE AND ITS DERIVATIVES ON BOVINE ERYTHROCYTE MEMBRANE
- Quantitative Taste Evaluation of Total Enteral Nutrients
- Bitterness Evaluation of Medicines for Pediatric Use by a Taste Sensor
- The Combination Effect of L-Arginine and NaCl on Bitterness Suppression of Amino Acid Solutions
- The Effect of Various Substances on the Suppression of the Bitterness of Quinine-Human Gustatory Sensation, Binding, and Taste Sensor Studies
- A New Method for Evaluating the Bitterness of Medicines by Semi-continuous Measurement of Adsorption Using a Taste Sensor
- Preparation and Characterization of Insulin-Loaded Acrylic Hydrogels Containing Absorption Enhancers
- Quantitative Evaluation of the Bitterness of Commercial Medicines Using a Taste Sensor
- Preparation and Characterization of Acrylic Hydrogels Neutralized by Basic Amino Acids
- In Vivo Microdialysis to Determine the Relative Pharmacokinetics of Drugs
- SYNTHESIS OF VALPROYL-2-PYRROLIDINONE AND ITS EVALUATION AS A COGNITIVE DRUG WITH THE ABILITY TO MODULATE ACIDIC AMINO ACIDS IN THE BRAIN
- Determination of γ-Aminobutyric Acid and Associated Amino Acids in Mouse Brain by Liquid Chromatography
- Famotidine Orally Disintegrating Tablets : Bitterness Comparison of Original and Generic Products
- Suppression of Bitterness and Improvement of Palatability of Commercial Prednisolone Powder
- Quality of Twelve Clarithromycin Dry Syrup Formulations-Bitterness, Grittiness and Uniformity of Drug Loading
- Inhibitory Effect of Aroma on the Bitterness of Branched-Chain Amino Acid Solutions
- Evaluation of Myopathy Risk for HMG-CoA Reductase Inhibitors by Urethane Infusion Method
- Zero-Order Release from Cylindrical Xerogel Preparation
- The Quantitative Prediction of Bitterness-Suppressing Effect of Sweeteners on the Bitterness of Famotidine by Sweetness-Responsive Sensor
- Factors Associated with Phlebitis and Venous Pain due to Intravenous Injection of Epirubicin Hydrochloride
- Preparation and Characterization of Polylactic Acid Microspheres Containing Water-Soluble Anesthetics with Small Molecular Weight
- PRODUCT INHIBITION OF AMINOPYRINE N-DEMETHYLATION IN ISOLATED HEPATOCYTES
- EFFECT OF ENVIRONMENTAL TEMPERATURE ON THE CONTENT OF CYTOCHROME P-450 AND ACTIVITY OF NADPH-CYTOCHROME C REDUCTASE IN RATS
- INFLUENCE OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE ON THE METABOLISM OF AMINOPYRINE IN ISOLATED HEPATOCYTE SYSTEM
- TISSUE DISTRIBUTION OF ISONIAZID AND ITS METABOLITES IN RATS
- STUDIES ON THE MECHANISM OF HYDRAZINES FORMATION FROM ISONIAZID AND THEIR DISTRIBUTION IN THE MAIN ORGANS
- METABOLISM OF ISONIAZID AND FREE HYDRAZINE FORMATION IN ISOLATED RAT HEPATOCYTES
- Statistical analysis of the adverse effects of glycopeptide antibiotics, based on pharmacokinetics and toxicokinetics (PK/TK)
- Bitterness Suppression of BCAA Solutions by L-Ornithine
- A New Method for Evaluating the Bitterness of Medicines in Development Using a Taste Sensor and a Disintegration Testing Apparatus
- The Suppression of Enhanced Bitterness Intensity of Macrolide Dry Syrup Mixed with an Acidic Powder
- An Attempt to Evaluate the Effect of Vitamin K_3 Using as an Enhancer of Anticancer Agents(Pharmacology)
- TISSUE DISTRIBUTION OF HYDRAZINE AND ITS METABOLITES IN RATS
- Preparation and Characterization of Polylactic Acid Microspheres Containing Bovine Insulin by a w/o/w Emulsion Solvent Evaporation Method
- Effect of Cholestyramine on the Pharmacokinetics and Pharmacodynamics of Bezafibrate in Rats
- ENHANCED MYOPATHY FOLLOWING ADMINISTRATION OF HYPOLIPIDEMIC AGENTS UNDER URETHANE ANESTHESIA
- Drug Interaction between Simvastatin and Cholestyramine in Vitro and in Vivo
- Usefulness of Questions from Patients and Their Families in Medication Guidance : Role of the Pharmacist in Integrated Therapy for Blood Cancer
- FATE OF DRUGS IN MAN UNDER GASTRIC CONDITIONS-WITH SPECIAL REFERENCE TO HYDRALAZINE
- CHARACTERISTIC BIOTRANSFORMATION OF AMINOPYRINE IN RAT WHEN ADMINISTERED WITH BARBITAL
- SALIVARY CONCENTRATION OF AMINOPYRINE AND ITS METABOLITES IN MAN
- QUANTITATIVE DETERMINATION OF HYDRAZINES DERIVED FROM ISONIAZID IN PATIENTS. I